Cellular Activity of CQWW Nullomer-Derived Peptides.

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• The UniProtKB/Swiss-Prot database analysis identified CQWW as the shortest absent amino acid sequence in observed proteins.
• This 'nullomer' sequence, though encoded by DNA, is not found in curated protein sets, indicating a biological translation or stability anomaly.

Purpose of the Study:

• To synthesize and evaluate the therapeutic potential of the nullomer peptide CQWW and its derivatives.
• To investigate the anti-cancer activity of nullomer peptides against glioblastoma cell lines.

Main Methods:

• Synthesis of the nullomer peptide CQWW and 13 derivatives, including reversed, truncated, and stereoisomers.
• Conjugation of peptides to polyarginine for enhanced cellular uptake.
• Testing peptide efficacy against a healthy neuronal line and six patient-derived glioblastoma cell lines.
• High-content phenotypic analysis and reverse-phase protein arrays to determine the mode of action.

Main Results:

• Nullomer peptides demonstrated an average IC50 of 4.9 μM for inhibiting glioblastoma cell survival.
• The mode of action was not clearly defined but suggested mitochondrial impairment.
• Evidence included reduced mitochondrial stain intensities and inhibition of GSK3 and its isoforms.

Conclusions:

• The synthesized nullomer peptide CQWW exhibits promising anti-cancer activity against glioblastoma.
• Mitochondrial impairment is a potential mechanism of action for nullomer peptides.
• Further research into nullomer peptides is warranted due to their potential therapeutic applications in oncology.